Litcius/Paper detail

Long COVID 1 year after hospitalisation for COVID-19: a prospective bicentric cohort study

Christoph Becker, Katharina Beck, Samuel Zumbrunn, Valentina Memma, Naemi Herzog, Benjamin Bissmann, Sebastian Gross, Nina Loretz, Jonas Mueller, Simon A. Amacher, Chantal Bohren, Rainer Schaefert, Stefano Bassetti, Christoph Fux, Beat Mueller, Philipp Schuetz, Sabina Hunziker

2021Swiss Medical Weekly48 citationsDOIOpen Access PDF

Abstract

AIMS OF THE STUDY: There is increasing interest in better understanding of long COVID, a condition characterised by long-term sequelae — appearing or persisting after the typical convalescence period — of coronavirus disease 2019 (COVID-19). Herein, we describe long-term outcomes regarding residual symptoms and psychological distress in hospitalised patients 1 year after COVID-19. METHODS: This prospective cohort study included consecutive adult patients hospitalised for confirmed COVID-19 in two Swiss tertiary-care hospitals between March and June 2020. The primary endpoint was evidence of long COVID 1 year after discharge, defined as ≥1 persisting or new symptom related to COVID-19, from a predefined list of symptoms. Secondary endpoints included psychological distress and symptoms of post-traumatic stress disorder (PTSD). RESULTS: Among 90 patients included in the study, 63 (70%) had symptoms of long COVID 1 year after hospitalisation, particularly fatigue (46%), concentration difficulties (31%), shortness of breath (21%) and post-exertion malaise (20%). Three predictors, namely duration of hospitalisation (odds ratio [OR] 1.11, 95% confidence interval [CI] 1.00–1.22; p = 0.041), severity of illness (OR 1.19, 95% CI 1.04–1.37; p = 0.013), and self-perceived overall health status 30 days after hospitalisation (OR 0.97, 95% CI 0.94–1.00; p = 0.027) were associated with long COVID. Regarding secondary endpoints, 16 (18%) experienced psychological distress and 3 (3.3%) patients had symptoms of PTSD. CONCLUSION: A high proportion of COVID-19 patients report symptoms of long COVID 1 year after hospitalisation, which negatively affects their quality of life. The most important risk factors were severe initial presentation of COVID-19 with long hospital stays.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)ImmunityAntibodyImmunologyPandemicCD8Cellular immunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immune systemProspective cohort studyVirusCohort2019-20 coronavirus outbreakVirologyInternal medicineDiseaseOutbreakInfectious disease (medical specialty)Long-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies